Literature DB >> 2980764

Historical aspects of inflammatory bowel disease.

J B Kirsner1.   

Abstract

Ulcerative colitis and regional enteritis (Crohn's disease), probably first appeared as isolated cases, several centuries ago; but not until the latter half of the 19th century did their clinical presentation attract medical interest as definable entities. This review of the early medical literature reveals a surprising number of reports of inflammatory bowel disease consistent with present descriptions of these conditions. As with other diseases, the steadily increasing numbers of patients with ulcerative colitis during the first third of the 20th century and of patients with regional enteritis during the latter two thirds of the century follows a familiar pattern encountered with diseases wherein environmental factors play a pathogenetic role. The early history of ulcerative colitis is lost in the complex mixture of infectious colitides, only partially unraveled in the past 100 years. The early history of regional enteritis probably is linked with the numerous European and American reports of tumor-like granulomas of the small intestine, initially regarded as neoplastic lesions requiring surgical removal. It now seems possible that physicians over a period of several centuries may have encountered these conditions but were not in a position to appreciate their uniqueness. The careful accounts of many authors, especially Morgagni (1761), Wilks (1859), Fenwick (1889), Dalziel (1913) and of Crohn, Ginzburg, and Oppenheimer (1932) of then obscure intestinal inflammatory processes thus re-emphasizes the importance of meticulous clinical and pathological descriptions in the subsequent elucidation of obscure disorders. If the course of ulcerative colitis and of Crohn's disease follow the historical pattern of other once important and later disappearing human illnesses, we may have reason to anticipate clarification of their etiology and possible relationship in the not too distant future.

Entities:  

Mesh:

Year:  1988        PMID: 2980764     DOI: 10.1097/00004836-198806000-00012

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  23 in total

1.  Environmental factors associated with Crohn's disease in India.

Authors:  Srinivasan Pugazhendhi; Manoj Kumar Sahu; Venkataraman Subramanian; Anna Pulimood; Balakrishnan S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2011-12-13

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 3.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

Review 4.  From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease.

Authors:  Charles W Randall; John A Vizuete; Nicholas Martinez; John J Alvarez; Karthik V Garapati; Mazyar Malakouti; Carlo M Taboada
Journal:  Therap Adv Gastroenterol       Date:  2015-05       Impact factor: 4.409

5.  Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth.

Authors:  Dandan Li; Youyu Zhang; Kun Liu; Yujie Zhao; Beibei Xu; Liang Xu; Li Tan; Yuan Tian; Cunxi Li; Wenqing Zhang; Hanwei Cao; Yan-Yan Zhan; Tianhui Hu
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

6.  Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells.

Authors:  S Sakamaki; N Takayanagi; N Yoshizaki; S Hayashi; T Takayama; J Kato; K Kogawa; N Yamauchi; N Takemoto; A Nobuoka; T Ayabe; Y Kohgo; Y Niitsu
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

7.  Ulcerative colitis complicated by gastroduodenal lesions.

Authors:  M Sasaki; K Okada; S Koyama; U Yoshioka; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

Review 8.  The microbial basis of inflammatory bowel diseases.

Authors:  Sushila R Dalal; Eugene B Chang
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

Review 9.  Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?

Authors:  Vanessa A Leone; Candace M Cham; Eugene B Chang
Journal:  Curr Opin Immunol       Date:  2014-09-15       Impact factor: 7.486

Review 10.  Role of antibiotics for treatment of inflammatory bowel disease.

Authors:  Orna Nitzan; Mazen Elias; Avi Peretz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.